Investigating how lung cell proteins respond to infections
Lung Endothelial Aß in infectious proteinopathy
This study is looking at how certain cells in the lungs react to pneumonia-causing bacteria by producing proteins called amyloids, which can either help fight the infection or cause problems, with the goal of finding new ways to improve treatment for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Alabama NIH-funded |
| Lab location | 1 site (Mobile, United States) |
| Project ID | NIH-10650303 on NIH RePORTER |
What this research studies
This research focuses on understanding how lung endothelial cells produce amyloids in response to infections, particularly from bacteria that cause pneumonia. It examines the dual nature of these amyloids, which can either help fight infections or cause harm to the body. The study utilizes advanced techniques like RNA sequencing and microarray analysis to explore the mechanisms behind the production of cytotoxic amyloids and their impact on critical illness. By identifying key proteins involved in this process, the research aims to uncover potential therapeutic targets for improving patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include critically ill patients with pneumonia or those at risk of developing lung infections.
Not a fit: Patients with non-infectious lung conditions or those not experiencing critical illness may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the body's ability to fight infections while minimizing damage to lung tissue.
How similar studies have performed: Other research has shown promise in understanding the role of amyloids in infections, suggesting that this approach could yield valuable insights.
Where this research is happening
Mobile, United States
- University of South Alabama — Mobile, United States (Active)
Researchers
- Principal investigator: Stevens, Troy — University of South Alabama
- Study coordinator: Stevens, Troy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.